In this study, the expression of plasma GFAP, NfL, and p-tau181 in patients with AD was significantly higher than those in the CU or MCI groups, with remarkable differences in pairwise comparisons (CU vs. AD, p < 0.0001; MCI vs. AD, p < 0.001). Here, GFAP is linked to Alzheimer disease.